CN111821210A - 含催泪蛋白的改善皮肤屏障及增强保湿的化妆材料组合物 - Google Patents
含催泪蛋白的改善皮肤屏障及增强保湿的化妆材料组合物 Download PDFInfo
- Publication number
- CN111821210A CN111821210A CN201911077014.2A CN201911077014A CN111821210A CN 111821210 A CN111821210 A CN 111821210A CN 201911077014 A CN201911077014 A CN 201911077014A CN 111821210 A CN111821210 A CN 111821210A
- Authority
- CN
- China
- Prior art keywords
- lachrymatory
- skin barrier
- protein
- moisture retention
- material composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2019-0045410 | 2019-04-18 | ||
KR1020190045410A KR102337935B1 (ko) | 2019-04-18 | 2019-04-18 | 라크리틴을 포함하는 피부장벽 개선 및 보습 증진용 화장료 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111821210A true CN111821210A (zh) | 2020-10-27 |
Family
ID=72911604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911077014.2A Pending CN111821210A (zh) | 2019-04-18 | 2019-11-06 | 含催泪蛋白的改善皮肤屏障及增强保湿的化妆材料组合物 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102337935B1 (ko) |
CN (1) | CN111821210A (ko) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395278A2 (en) * | 2001-02-20 | 2004-03-10 | University Of Virginia Patent Foundation | Ocular tear growth factor-like protein |
JP2005272445A (ja) * | 2004-02-27 | 2005-10-06 | Fuso Pharmaceutical Industries Ltd | 涙液分泌促進ペプチドおよびその組成物 |
WO2005119899A2 (en) * | 2004-05-13 | 2005-12-15 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
JP2006129724A (ja) * | 2004-11-02 | 2006-05-25 | Senju Pharmaceut Co Ltd | ラクリチン活性を有する化合物のスクリーニング方法 |
WO2006129867A2 (en) * | 2005-06-01 | 2006-12-07 | Senju Pharmaceutical Co., Ltd. | ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
CN102083974A (zh) * | 2008-03-19 | 2011-06-01 | 千寿制药株式会社 | 催泪蛋白的部分肽 |
EP2453838A2 (en) * | 2009-07-16 | 2012-05-23 | L'Oréal | Cosmetic use of lacritin-type polypeptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05122278A (ja) | 1991-10-30 | 1993-05-18 | Nec Corp | 交換機の端末制御方式 |
KR100371966B1 (ko) * | 2000-11-17 | 2003-02-14 | 엔프라니 주식회사 | 피지 조절용 화장료 조성물 |
ATE412342T1 (de) * | 2005-04-01 | 2008-11-15 | Hamlet Protein As | Fermentiertes proteinprodukt |
WO2011034207A1 (en) | 2009-09-16 | 2011-03-24 | Senju Pharmaceutical Co., Ltd. | Partial peptide of lacritin |
JP6320867B2 (ja) | 2014-07-23 | 2018-05-09 | キユーピー株式会社 | 乳酸発酵卵白配合化粧料及びその製造方法 |
-
2019
- 2019-04-18 KR KR1020190045410A patent/KR102337935B1/ko active IP Right Grant
- 2019-11-06 CN CN201911077014.2A patent/CN111821210A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395278A2 (en) * | 2001-02-20 | 2004-03-10 | University Of Virginia Patent Foundation | Ocular tear growth factor-like protein |
JP2005272445A (ja) * | 2004-02-27 | 2005-10-06 | Fuso Pharmaceutical Industries Ltd | 涙液分泌促進ペプチドおよびその組成物 |
WO2005119899A2 (en) * | 2004-05-13 | 2005-12-15 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
JP2006129724A (ja) * | 2004-11-02 | 2006-05-25 | Senju Pharmaceut Co Ltd | ラクリチン活性を有する化合物のスクリーニング方法 |
WO2006129867A2 (en) * | 2005-06-01 | 2006-12-07 | Senju Pharmaceutical Co., Ltd. | ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
CN102083974A (zh) * | 2008-03-19 | 2011-06-01 | 千寿制药株式会社 | 催泪蛋白的部分肽 |
EP2453838A2 (en) * | 2009-07-16 | 2012-05-23 | L'Oréal | Cosmetic use of lacritin-type polypeptides |
Also Published As
Publication number | Publication date |
---|---|
KR102337935B1 (ko) | 2021-12-10 |
KR20200122569A (ko) | 2020-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9089504B2 (en) | Cosmetic composition containing green tea component | |
EP1638991B1 (fr) | Composition cosmetique ou dermopharmaceutique pour reduire les signes du vieillissement cutane | |
EP1021161B1 (fr) | Utilisation de l'acide ellagique et de ses derives en cosmetique et en dermatologie | |
US20090010976A1 (en) | Cosmetic or dermopharmaceutical compositions containing kombucha | |
CN103635102A (zh) | 皮肤病学活性酵母提取物 | |
US20190111108A1 (en) | Composition Including GDF11 and Use Thereof | |
US20130183257A1 (en) | Compositions and methods for improving skin appearance | |
KR101855207B1 (ko) | 흑효모 발효를 통해 비타민 c 함량이 증가된 카카두플럼 추출물을 함유하는 화장료 조성물 | |
KR101917645B1 (ko) | 사카로미세스 효모발효여과물, 아스파라거스줄기 추출물 및 관동꽃 추출물을 포함하는 화장료 조성물 | |
CN110870880A (zh) | 包含异常毕赤酵母和视黄醇的局部用组合物 | |
KR101841118B1 (ko) | 세네데스무스 속 미세조류의 추출물을 유효성분으로 함유하는 피부 외용제 조성물 | |
KR102065905B1 (ko) | 바실러스 푸밀루스 균주 또는 이의 배양액을 포함하는 노화 예방 또는 개선용 조성물 | |
US9629823B2 (en) | Composition for promoting collagen production, for promoting elastin production and/or for promoting keratinocyte migration and usage therefor | |
FR2997853A1 (fr) | Utilisation d'extrait de myrothamnus flabellifolia et de rhamnose pour lutter contre les signes du vieillissement cutane. | |
KR20190062173A (ko) | 프로테아제활성화수용체(par2)의 작용제를 포함하는 피부 주름 개선 또는 노화 방지용 화장료 조성물 | |
US20200315951A1 (en) | Skin whitening composition comprising culture of pseudoalteromonas carrageenovora or extract thereof | |
CN111821210A (zh) | 含催泪蛋白的改善皮肤屏障及增强保湿的化妆材料组合物 | |
KR20190021114A (ko) | 식물 추출물을 포함하는 피부 항염, 피지 분비 억제용, 또는 여드름 개선용 조성물 | |
KR101997231B1 (ko) | 효소반응을 이용하여 제조된 꿀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101303294B1 (ko) | 한련초 추출물, 지구자 추출물 및 밀싹 추출물을 유효성분으로 포함하는 기미, 검버섯, 주근깨 등의 잡티 제거 및 각질 박리 촉진용 화장료 조성물 | |
KR102233916B1 (ko) | Pq1 숙신산을 포함하는 피부 보습, 주름 개선 및 탄력 증진용 조성물 | |
KR20100114563A (ko) | 피부에 미백효과가 있는 발효 유청과 그것을 함유한 피부 외용제 조성물 | |
KR102652692B1 (ko) | 남극 미생물 배양액을 포함하는 화장료 조성물 | |
KR20190048768A (ko) | 케라틴 펩타이드를 유효성분으로 포함하는 모발 및 두피용 화장료 조성물 | |
KR20110101727A (ko) | 주름 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |